Assessment of socio-economic availability of spironolactone diuretics (С03DA01) and furosemide (C03CA01) of the domestic pharmaceutical market
Journal Title: Соціальна фармація в охороні здоров’я - Year 2019, Vol 5, Issue 1
Abstract
The results of market monitoring of diuretics recommended for the treatment of liver cirrhosis complications have been analyzed in the article. From 01/01/2017 till 31/12/2018 a monthly monitoring of the physical and socio-economic availability for domestic patients with ascites was performed. Aim. To interpret the dynamics of data of the marketing analysis of medicines recommended for the treatment of patients with liver cirrhosis and its most common complication – ascites. Materials and methods. Marketing analysis carried out by the method of monthly monitoring of the range, average wholesale and selling prices, indicators of socio-economic availability (price liquidity ratios, adequacy of solvency of the population, , availability (D) of medicines) according to the data “The software complex “Apteka” resource (http://pharmbase.com.ua/) for the period of 01.01.2017-31.12.2018. Results. It has been found out that diuretics of spironolactone (C03DA01) and furosemide (C03CA01) groups are sufficiently represented at the domestic pharmaceutical market; their socio-economic availability has shown a positive dynamics. Among the medicines of spironolactone the lowest wholesale and retail price was for Spironolacton-Darnitsa, PrAS FF “Darnitsa”, while the highest price was for Veroshpiron, Gedeon Richter; among the medicines of furosemide – for Furosemid, LTD RP “GNSSLS” and Lazyx, “Sanofi India Limited”, respectively. A sharp reduction in prices for some drugs was due to the inclusion of active substances in the Government program “Available medicines”, and the period of decline in cost coincided with the time of their introduction into the Register of Medicines, which cost was subjected to compensation. As for range in prices, they were due to the fluctuation of the hryvnia against the dollar in 2017-2018. Conclusions. The assessment of the social-economic availability of diuretics of the spironolactone and furosemide groups by monitoring of the liquidity ratios (Cliq), adequacy of the population’s solvency (Сa.s), availability (D) of medicines allows them to be considered financially affordable for an average inhabitant suffering from ascites because of liver cirrhosis. The market window for the future domestic medicine based on the combination of spironolactone and furosemide (100 mg + 40 mg, respectively) has been identified, it is expected to have a price advantage over the imported analog.
Authors and Affiliations
I. O. Fedyak, O. V. Maksymenko
Keywords
Related Articles
- EP ID EP662756
- DOI 10.24959/sphhcj.19.140
- Views 173
- Downloads 0
Analysis of the pharmaceutical market of medicines with the immunomodulatory activity in Ukraine
Aim. To conduct the analysis of the domestic pharmaceutical market of medicines with the immunomodulatory activity taking into account all their dosage forms. Materials and Methods. The analysis was conducted on the basi...
Конвенция «Медикрим» как инструмент противодействия подделке медицинской продукции в Украине
Цель: исследование соответствия мер, предусмотренных Конвенцией «Медикрим», организационно-правовым мерам, применямым в Украине с целью повышения эффективности противодействия подделке медицинской продукции, а также выра...
Обґрунтування технології виготовлення крему зі срібла цитратом
Мета: обґрунтування технології виготовлення ветеринарного крему зі срібла цитратом та дослідження впливу умов виготовлення на якість готового продукту. Матеріали та методи. Дослідження проводили зі зразками крему, одержа...
Фармакоэпидемиологический и клинико-экономический анализ потребления антибактериальных препаратов в многопрофильном стационаре
Сведения о потреблении антимикробных препаратов в стационарах косвенно отражают выполнение стандартов медицинской помощи, а также представления медицинских работников о проблемах профилактики и лечения инфекционных забол...
Исследования по разработке жидкого экстракта бронхолитического действия
Цель: определение экстрагента и кратности экстракции с использованием метода перколяции при разработке технологии получения экстракта бронхолитического действия. Материалы и методы. Для определения оптимальных условий эк...